comparemela.com

Latest Breaking News On - Pipeline studies and drug development - Page 1 : comparemela.com

Microbiome Global Market to Reach $1 93 Billion by 2031 with a CAGR of 15 4%

/PRNewswire/ The "Microbiome Global Market Opportunities And Strategies To 2031" report has been added to ResearchAndMarkets.com s offering. The global.

United statesAsia pacificLaura woodEnterome bioscienceE st office hours callPipeline studies and drug developmentMicrobiome market competitive landscape and company profilesOffice hours callInvestments in developmentFerring pharmaceuticalsSecond genome incWestern europeNorth americaPrinting andDiagnostics by microbiome therapeuticInfectious diseases

Global $14 9 Bn Nucleic Acid Based Gene Therapy Markets,

Dublin, April 07, 2022 (GLOBE NEWSWIRE) The "Nucleic Acid Based Gene Therapy Global Market Opportunities And Strategies To 2030, By Nucleic Acid.

United statesBenitec biopharmaOxford biomedicaAsia pacificAcademic and research institutesPipeline studies and drug developmentNucleic acid technologySegmentation by technologyModerna incSarepta therapeutics incSegmentation by nucleic acid technologyGlobal research initiatives and fundingWave life sciencesWestern europeMiddle eastEastern europe

Nucleic Acid Based Gene Therapy Global Market Opportunities and Strategies to 2030 - ResearchAndMark

DUBLIN (BUSINESS WIRE) The "Nucleic Acid Based Gene Therapy Global Market Opportunities And Strategies To 2030, By Nucleic Acid Technology, Application, End User" report has been added to ResearchAndMarkets.com's offering.The global nucleic acid-based gene therapy market grew from $1,391.9 million in 2015 to $4,72.

United statesBenitec biopharmaOxford biomedicaAsia pacificLaura woodAcademic and research institutesPipeline studies and drug developmentNucleic acid technologyOffice hours callE st office hours callSegmentation by technologyModerna incSarepta therapeutics incSegmentation by nucleic acid technologyGlobal research initiatives and fundingWave life sciences

vimarsana © 2020. All Rights Reserved.